These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 11051284

  • 1. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F, Spagnoli A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G, Verrotti A.
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [Abstract] [Full Text] [Related]

  • 2. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N, Fuller JH, Pokras F, Rottiers R, Papazoglou N, Aiello LP, EUCLID Study Group.
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [Abstract] [Full Text] [Related]

  • 3. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F, de Martino M, Mezzetti A, Catino M, Morgese G, Cuccurullo F, Verrotti A.
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS.
    Pediatr Res; 1998 Dec; 44(6):873-5. PubMed ID: 9853920
    [Abstract] [Full Text] [Related]

  • 5. Serum angiogenin concentrations in young patients with diabetes mellitus.
    Chiarelli F, Pomilio M, Mohn A, Tumini S, Verrotti A, Mezzetti A, Cipollone F, Wasniewska M, Morgese G, Spagnoli A.
    Eur J Clin Invest; 2002 Feb; 32(2):110-4. PubMed ID: 11895457
    [Abstract] [Full Text] [Related]

  • 6. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria.
    Santilli F, Spagnoli A, Mohn A, Tumini S, Verrotti A, Cipollone F, Mezzetti A, Chiarelli F.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3871-6. PubMed ID: 11502826
    [Abstract] [Full Text] [Related]

  • 7. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 8. [Metabolic control in children and adolescents with diabetes mellitus type I in Berne: a cross-sectional study].
    Flück CE, Kuhlmann BV, Mullis PE.
    Schweiz Med Wochenschr; 1999 Nov 06; 129(44):1650-5. PubMed ID: 10588023
    [Abstract] [Full Text] [Related]

  • 9. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
    Myśliwiec M, Balcerska A, Zorena K, Myśliwska J, Lipowski P, Raczyńska K.
    Klin Oczna; 2007 Nov 06; 109(4-6):150-4. PubMed ID: 17725274
    [Abstract] [Full Text] [Related]

  • 10. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep 06; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 11. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F, Catino M, Tumini S, Cipollone F, Mezzetti A, Vanelli M, Verrotti A.
    Pediatr Nephrol; 2000 Aug 06; 14(8-9):841-6. PubMed ID: 10955941
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the vascular endothelial growth factor in children and adolescents with type 1 diabetes].
    Peczyńska J, Urban M, Urban B, Głowińska B.
    Pol Merkur Lekarski; 2004 May 06; 16(95):438-42. PubMed ID: 15518422
    [Abstract] [Full Text] [Related]

  • 13. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.
    Shimada K, Baba T, Neugebauer S, Onozaki A, Yamada D, Midorikawa S, Sato W, Watanabe T.
    J Diabetes Complications; 2002 May 06; 16(6):386-90. PubMed ID: 12477622
    [Abstract] [Full Text] [Related]

  • 14. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D, Salemyr J, Örtqvist E, Juul A, Bang P.
    Pediatr Diabetes; 2018 Aug 06; 19(5):972-978. PubMed ID: 29663652
    [Abstract] [Full Text] [Related]

  • 15. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P, Tarnow L, Oestergaard PB, Parving HH.
    Kidney Int Suppl; 2000 Apr 06; 75():S56-61. PubMed ID: 10828763
    [Abstract] [Full Text] [Related]

  • 16. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R.
    Diabetes Care; 2001 Mar 06; 24(3):516-21. PubMed ID: 11289478
    [Abstract] [Full Text] [Related]

  • 17. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K, Sandler S, Espes D.
    J Diabetes Res; 2017 Mar 06; 2017():6192896. PubMed ID: 28421206
    [Abstract] [Full Text] [Related]

  • 18. Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy.
    Knott RM, Pascal MM, Ferguson C, Leiper J, Olson J, Muckersie E, Robertson M, Forrester JV.
    Metabolism; 1999 Sep 06; 48(9):1172-8. PubMed ID: 10484060
    [Abstract] [Full Text] [Related]

  • 19. Soluble CD40L in children and adolescents with type 1 diabetes: relation to microvascular complications and glycemic control.
    El-Asrar MA, Adly AA, Ismail EA.
    Pediatr Diabetes; 2012 Dec 06; 13(8):616-24. PubMed ID: 22702645
    [Abstract] [Full Text] [Related]

  • 20. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA, Andrawes NG, Ismail EA, Salem SM.
    Vasc Med; 2015 Dec 06; 20(6):509-17. PubMed ID: 26091968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.